RPG LIFE SCIENCES Financial Statement Analysis
|
||
|
The Revenues of RPG LIFE SCIENCES have increased by 16.51% YoY .
The Earnings Per Share (EPS) of RPG LIFE SCIENCES has increased by 31.38 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
RPG LIFE SCIENCES Last 5 Annual Financial Results
[BOM: 532983|NSE : RPGLIFE]
| Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
|---|---|---|---|---|---|
| Revenues | ₹513 Cr | ₹440 Cr | ₹389 Cr | ₹376 Cr | ₹330 Cr |
| Expenses | ₹409 Cr | ₹353 Cr | ₹318 Cr | ₹316 Cr | ₹296 Cr |
| Operating Profit (Excl OI) | ₹104 Cr | ₹87 Cr | ₹71 Cr | ₹60 Cr | ₹34 Cr |
| Other Income | ₹4.80 Cr | ₹3.08 Cr | ₹1.07 Cr | ₹0.99 Cr | ₹0.80 Cr |
| Interest | ₹1.15 Cr | ₹1.41 Cr | ₹1.79 Cr | ₹2.76 Cr | ₹4.86 Cr |
| Depreciation | ₹15 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr |
| Profit Before Tax | ₹92 Cr | ₹73 Cr | ₹54 Cr | ₹36 Cr | ₹15 Cr |
| Profit After Tax | ₹68 Cr | ₹51 Cr | ₹40 Cr | ₹29 Cr | ₹11 Cr |
| Consolidated Net Profit | ₹68 Cr | ₹51 Cr | ₹40 Cr | ₹29 Cr | ₹11 Cr |
| Earnings Per Share (Rs) | ₹40.90 | ₹31.13 | ₹24.19 | ₹17.54 | ₹6.54 |
| PAT Margin (%) | 12.19 | 10.74 | 9.53 | 7.72 | 3.27 |
| ROE(%) | 24.01 | 21.80 | 20.36 | 17.21 | 6.86 |
| ROCE(%) | 32.92 | 31.46 | 27.27 | 20.35 | 9.81 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.01 | 0.07 | 0.23 |
Key Financials |
||
| Market Cap | : | ₹ 2,458.1 Cr |
| Revenue (TTM) | : | ₹ 573.6 Cr |
| Net Profit(TTM) | : | ₹ 84.8 Cr |
| EPS (TTM) | : | ₹ 51.4 |
| P/E (TTM) | : | 29.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| RPG LIFE SCIENCES | -0.4% | -8.1% | 102.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
| CIPLA | 2.5% | 0.4% | 71.7% |
| DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
| ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
| DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
| MANKIND PHARMA | NA | NA | NA |
| TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
| LUPIN | 2.8% | 0% | 147.8% |
RPG LIFE SCIENCES Revenues
[BOM: 532983|NSE : RPGLIFE]
| Y-o-Y | 16.51 % |
| 5 Yr CAGR | 11.64 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2023 | ₹513 Cr | 16.51 | |
| Mar2022 | ₹440 Cr | 13.11 | |
| Mar2021 | ₹389 Cr | 3.61 | |
| Mar2020 | ₹376 Cr | 13.75 | |
| Mar2019 | ₹330 Cr | - | |
RPG LIFE SCIENCES Operating Profit
[BOM: 532983|NSE : RPGLIFE]
| Y-o-Y | 18.77 % |
| 5 Yr CAGR | 31.68 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2023 | ₹104 Cr | 18.77 | |
| Mar2022 | ₹87 Cr | 23.16 | |
| Mar2021 | ₹71 Cr | 18.15 | |
| Mar2020 | ₹60 Cr | 73.98 | |
| Mar2019 | ₹34 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 1.97 % |
| 5 Yr CAGR | 17.95 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2023 | 20.19% | 1.97 | |
| Mar2022 | 19.8% | 8.85 | |
| Mar2021 | 18.19% | 14.04 | |
| Mar2020 | 15.95% | 52.92 | |
| Mar2019 | 10.43% | - | |
RPG LIFE SCIENCES Profit After Tax
[BOM: 532983|NSE : RPGLIFE]
| Y-o-Y | 31.39 % |
| 5 Yr CAGR | 58.16 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2023 | ₹68 Cr | 31.39 | |
| Mar2022 | ₹51 Cr | 28.70 | |
| Mar2021 | ₹40 Cr | 37.88 | |
| Mar2020 | ₹29 Cr | 168.36 | |
| Mar2019 | ₹11 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 13.50 % |
| 5 Yr CAGR | 38.95 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2023 | 12.19 % | 13.50 | |
| Mar2022 | 10.74 % | 12.70 | |
| Mar2021 | 9.53 % | 23.45 | |
| Mar2020 | 7.72 % | 136.09 | |
| Mar2019 | 3.27 % | - | |
RPG LIFE SCIENCES Earnings Per Share (EPS)
[BOM: 532983|NSE : RPGLIFE]
| Y-o-Y | 31.38 % |
| 5 Yr CAGR | 58.14 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2023 | ₹41 | 31.38 | |
| Mar2022 | ₹31 | 28.69 | |
| Mar2021 | ₹24 | 37.91 | |
| Mar2020 | ₹18 | 168.20 | |
| Mar2019 | ₹6.54 | - | |
RPG LIFE SCIENCES Return on Capital Employed (ROCE)
[BOM: 532983|NSE : RPGLIFE]
| Y-o-Y | 4.64 % |
| 5 Yr CAGR | 35.35 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2023 | 32.92% | 4.64 | |
| Mar2022 | 31.46% | 15.36 | |
| Mar2021 | 27.27% | 34.00 | |
| Mar2020 | 20.35% | 107.44 | |
| Mar2019 | 9.81% | - | |
RPG LIFE SCIENCES Share Price vs Sensex
| Current Share Price | : | ₹1,489.8 |
| Current MarketCap | : | ₹ 2,458.1 Cr |
| Updated EOD on | : | Apr 19,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| RPG LIFE SCIENCES | -0.4% |
-8.1% |
102.8% |
| SENSEX | -2.6% |
-0% |
21% |
RPG LIFE SCIENCES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE SMALL CAP | -1.6% | 8.4% | 61.4% |
| S&P BSE MIDSMALLCAP | -2.1% | 6.3% | 61.6% |
| S&P BSE ALLCAP | -2.5% | 2.7% | 37.3% |
| S&P BSE HEALTHCARE | -3.6% | 0.7% | 51.1% |
No NSE index found
You may also like the below Video Courses
FAQ about RPG LIFE SCIENCES Financials
How the annual revenues of RPG LIFE SCIENCES have changed ?
The Revenues of RPG LIFE SCIENCES have increased by 16.51% YoY .
How the Earnings per Share (EPS) of RPG LIFE SCIENCES have changed?
The Earnings Per Share (EPS) of RPG LIFE SCIENCES has increased by 31.38 % YoY .
Check out Intrinsic Value of Peers of RPG LIFE SCIENCES
Compare Stock Analytics of Peers of RPG LIFE SCIENCES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
